Correspondence to Prescribers Related FilesMMP Preferred Product Brabio Communication to Prescribers January 2021Format:PDF|File Size:307KB BVB Medicine Letter to Prescribers January 2021Format:PDF|File Size:191KB Letter to prescribers removal of online application requirement for DOACs October 2020Format:PDF|File Size:142KB MMP BVB Medicine Letter to prescribers September 2020Format:PDF|File Size:610KB MMP BVB Medicine letter to prescribers new initiations January 2020Format:PDF|File Size:566KB Letter to prescribers and pharmacists in relation to the removal of the online application requirement for Apixaban September 2019Format:PDF|File Size:444KB Letter to prescribers re sacubitril and valsartan (Entresto) reimbursementFormat:PDF|File Size:307KB Preferred Drugs Initiative – Oral anticoagulants (Warfarin and NOACs)Format:PDF|File Size:228KB In this section Best-value medicines Latest Updates COVID-19 Data Snapshots and Publications Glucose monitoring Preferred Drugs Prescribing Tips and Tools Prescribing and Cost Guidance Managed Access Protocols Position Papers Evaluation Reports Consultation Correspondence to Prescribers Patient Information Lidocaine 5% plaster Oral nutritional supplements Opioids BZRA for anxiety & insomnia Oral anticoagulants Guidance on Shortages Events The Team / Contact Us
